S. 133 — Introduced in Senate

II 118th CONGRESS 1st Session S. 133 IN THE SENATE OF THE UNITED STATES January 30, 2023Ms. Collins (for herself, Mr. Warner, Mrs. Capito, Mr. Markey, Mr. Moran, Mr. Menendez, Ms. Murkowski, and Ms. Stabenow) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To extend the National Alzheimer's Project. 1. Short title This Act may be cited as the NAPA Reauthorization Act. 2. Extension of project Section 2 of the National Alzheimer's Project Act (42 U.S.C. 11225) is amended— (1) in subsection (c)— (A) in paragraph (2), by striking and coordination of and inserting on, and coordination of,; (B) in paragraph (4)— (i) by redesignating subparagraphs (A) and (B) as subparagraphs (B) and (C), respectively; and (ii) by inserting before subparagraph (B), as so redesignated, the following: (A) promotion of healthy aging and reduction of risk factors for Alzheimer's; ; (C) in paragraph (5), by striking ; and and inserting a semicolon; (D) by redesignating paragraph (6) as paragraph (7); and (E) by inserting after paragraph (5) the following: (6) provide information on, and promote the adoption of, healthy behaviors that may reduce the risk of cognitive decline and promote and protect cognitive health; and ; (2) in subsection (d)(2)— (A) by inserting , across public and private sectors, after Nation's progress; and (B) by inserting , including consideration of public-private collaborations, as appropriate before the period; (3) in subsection (e)— (A) in paragraph (2)— (i) in subparagraph (A), by adding at the end the following: (xi) A designee of the Department of Justice. (xii) A designee of the Federal Emergency Management Agency. (xiii) A designee of the Social Security Administration. (xiv) A designee of the Office of Management and Budget. (xv) 1 or more other designees of the Department of Health and Human Services, as determined by the Secretary of Health and Human Services. ; and (ii) in subparagraph (B)— (I) in clause (v)— (aa) by striking 2 researchers and inserting 3 researchers; and (bb) by striking ; and and inserting , including at least one researcher with demonstrated experience in recruitment and retention of diverse cohorts of trial participants;; (II) in clause (vi), by striking the period and inserting ; and; and (III) by adding at the end the following: (vii) an individual with a diagnosis of Alzheimer's disease. ; (B) in paragraph (5)— (i) in subparagraph (A)— (I) by striking an initial evaluation and inserting annual evaluations; and (II) by striking research, clinical and inserting research, risk reduction, public health, clinical; (ii) in subparagraph (B), by striking initial; (iii) in subparagraph (C)— (I) in the matter preceding clause (i), by striking initial; and (II) in clause (ii), by inserting and reduce disparities before the semicolon; and (iv) in subparagraph (D), by striking annually thereafter, an evaluation and inserting annual evaluations; and (C) in paragraph (6), by striking 2025 and inserting 2035; (4) in subsection (g)(3)(A)(ii), by inserting and reduce disparities before the semicolon; and (5) in subsection (h), by striking 2025 and inserting 2035.